Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Focus on hydration and consider herbal support like milk thistle or dandelion root
Joint pain diminishes
Saxenda (active ingredient: liraglutide) subcutaneous injection Initial FDA Approval: 2014 (liraglutide approved in 2010) Side Effect Update Date: May 28, 2025 Medication Description: For chronic weight management Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
insulin lispro The SURPASS-6 trial included 1,428 adults with type 2 diabetes inadequately controlled by basal insulin, comparing once-weekly tirzepatide (5 mg, 10 mg, 15 mg) with thrice-daily insulin lispro
Arioz DT et al
US$ 28.59
US$ 25.71
US$ 23.00
US$ 21.56
US$ 26.38
US$ 20.33
